Brooks Laboratories P/E Ratio
Current P/E Ratio
8.82
Low Valuation
Very Low - Potentially undervalued or facing challenges
Brooks Laboratories (BROOKS) P/E ratio is 8.82 (Low), EPS (TTM) ₹8.35, current price ₹72.07 on NSE — Very Low - Potentially undervalued or facing challenges. See BROOKS price book multiple to compare market price against book value per share.
Current Valuation Metrics
P/E Ratio
8.82
Current Price
₹72.07
EPS (TTM)
₹8.35
Exchange
NSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
55.49
Sector Median
31.4
Sector Rank
#11 of 194
Sector Percentile
5.7%
Earnings Breakdown (TTM)
TTM EPS
₹5.94
Mar 2026
₹0.52
Sept 2025
₹2.71
BROOKS P/E Ratio — Valuation Signal & Historical Context
Brooks Laboratories P/E 8.82 — signal: Undervalued. For live price, revenue and the complete fundamental profile, see BROOKS screener.
- Stock appears undervalued with PE of 8.82, suggesting potential buying opportunity
- Trading at discount to sector average PE of 55.49
BROOKS vs Healthcare Peers — P/E Ratio Comparison
Brooks Laboratories P/E 8.82 vs Healthcare average 55.49, median 31.4 — range 2.86–987.08.
Sector Average
55.49
Sector Median
31.4
Lowest P/E
2.86
Highest P/E
987.08
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.84 | ₹68 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |